Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 4/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | APEX1 | P27695 | 2/20 | 0.72 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.64 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.64 |
| ▸ | HPGDS | O60760 | 1/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.59 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13998613 | 0.94 | CHAT (0.64) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL11885184 | 0.94 | CHAT (0.63) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL13998614 | 0.94 | CHAT (0.64) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL14539837 | 0.92 | CHAT (0.61) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL8986185 | 0.92 | CHAT (0.73) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL12662773 | 0.90 | HPGDS (0.60) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL12172892 | 0.90 | CHAT (0.59) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL14981571 | 0.90 | CHAT (0.63) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL13891568 | 0.87 | CHAT (0.59) | CHATUSP2APEX1ENPP3ENPP1 | |
| SCHEMBL14642059 | 0.86 | HPGDS (0.58) | CHATUSP2APEX1ENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306600-A1 | REACTIVE DYE COMPOSITION AND APPLICATION THEREOF | Everlight Chemical Industrial Corporation (TW) | 2024-01-17 | — | — | EP | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2546309-B1 | ANTHRAPYRIDONE SULPHONIC ACID COMPOUNDS, PREPARATION AND USE THEREOF | UNIV DALIAN TECH (CN) | 2016-06-01 | — | — | EP | disclosed |
| US-8968453-B2 | Anthrapyridone sulfonic acid compounds and their preparation methods and applications | Zhuhai Ninestar Management Co., Ltd. (CN) | 2015-03-03 | — | — | US | disclosed |
| US-8968453-B2 | Anthrapyridone sulfonic acid compounds and their preparation methods and applications | Zhuhai Ninestar Management Co., Ltd. (CN) | 2015-03-03 | — | — | US | disclosed |
| EP-2546309-A1 | ANTHRAPYRIDONE SULPHONIC ACID COMPOUNDS, PREPARATION AND USE THEREOF | Dalian University Of Technology (CN) | 2013-01-16 | — | — | EP | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| WO-2010149505-A2 | CHARGED PARTICLES | BASF SE (DE) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | CHAT 1302/4885USP2 3518/4885APEX1 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.